1 Min Read
May 12 (Reuters) - Star Pharmaceutical Ltd
* qtrly revenue RMB19.9 million versus RMB15.6 million
* qtrly profit attributable RMB3.9 million versus RMB227,000 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.